Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 10,258 | 663 | 5,963 | 18,658 | 50,917 |
| Gross Profit | 10,258 | 663 | 5,963 | 18,658 | 50,917 |
| Operating Expenses | 29,930 | 28,594 | 21,731 | 19,944 | 28,296 |
| Operating Income | -19,672 | -27,931 | -15,768 | -1,286 | 22,621 |
| Other Income | 1,483 | 1,476 | 1,597 | 1,195 | 966 |
| Pre-tax Income | -18,189 | -26,455 | -14,171 | -91 | 23,587 |
| Income Tax | 59 | 55 | 58 | 63 | 62 |
| Net Income Continuous | -18,248 | -26,510 | -14,229 | -154 | 23,525 |
| Net Income | $-18,248 | $-26,510 | $-14,229 | $-154 | $23,525 |
| EPS Basic Total Ops | -0.10 | -0.33 | -0.09 | 0.00 | 0.27 |
| EPS Basic Continuous Ops | -0.10 | -0.31 | -0.09 | 0.00 | 0.27 |
| EPS Diluted Total Ops | -0.10 | -0.33 | -0.09 | 0.00 | 0.27 |
| EPS Diluted Continuous Ops | -0.10 | -0.31 | -0.09 | 0.00 | 0.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.22 | -0.09 | 0.00 | 0.27 |
| EBITDA(a) | $-20,147 | $-28,140 | $-16,270 | $-1,336 | $22,552 |